Search - tctmd.com

Displaying 1 - 20 of 70

Sort: Relevancy | Date

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

May 21, 2025

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

November 18, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Yael L. Maxwell

October 28, 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Safety Retained When Fellows Lead Complex PCI Procedures

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

News Conference News ESOC 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

May 23, 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

November 13, 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

November 11, 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

As Outpatient Facilities Proliferate, So Too Does Scrutiny

News Conference News ISET 2023

As Outpatient Facilities Proliferate, So Too Does Scrutiny

January 17, 2023

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

September 01, 2022

Robotic PCI Safe, Feasible in Noncomplex Cases: R-Evolution

News Conference News EuroPCR 2022

Robotic PCI Safe, Feasible in Noncomplex Cases: R-Evolution

Yael L. Maxwell

May 18, 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

GIRAF: Cognitive Outcomes Similar With Dabigatran, Warfarin in Older AF Patients

News Conference News AHA 2021

GIRAF: Cognitive Outcomes Similar With Dabigatran, Warfarin in Older AF Patients

November 14, 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.